[Hemato-encephalic barrier function in strokes in patients with arterial hypertension under drug correction].
Dunaev
V V
VV
Mazur
I A
IA
Petrenko
A G
AG
Belenichev
I F
IF
Kovalenko
S I
SI
Klimenko
V N
VN
Guĭtur
M M
MM
Vizir
V A
VA
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000187:drug effects*; D002543:Cerebral Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use; D052999:Quinazolinones; D051381:Rats; D017208:Rats, Wistar
D000975:Antioxidants; D006834:Hydrazines; D011799:Quinazolines; D052999:Quinazolinones; C085354:4-hydrazinoquinazoline